the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Pharmaceutical Market Research

<< Previous Page:   7   8   9   10   11   12   13   14   15   16   17   18   Next >>
 
Digestive Remedies in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Digestive Remedies in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. ...

Cough, Cold and Allergy (hay Fever) Remedies in Norway
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy Products in Norway report offers a comprehensive guide to the size and shape of the market at a national level. ...

Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Cough, Cold and Allergy Products in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. ...

Analgesics in Norway
Table of Contents Published: 2009/06 Published by: Euromonitor International
Euromonitor International' s Analgesics in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It id ...

Analgesics in Argentina
Table of Contents Published: 2009/06 Published by: Euromonitor International
The Argentine market for OTC healthcare products saw growth during 2008, due to higher advertising expenditure aiming to make consumers aware of the benefits of products such as Elea' s Mox 12 Hs naproxen, or Boehringer' s Buscapina Fem IBS treatment. Add ...

Global Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015
Table of Contents Published: 2009/06 Published by: Global Markets Direct
This report is an essential source for key information and data relating to global diabetes care devices market. The report provides global and country level, detailed and comprehensive coverage of market and category revenue, volume, distribution and com ...

Lymphoma Drug Development Strategies at Work - Define Your Competition
Table of Contents Published: 2009/06 Published by: BioSeeker Group AB
This report includes defined and up to date development strategies for 176 lymphoma therapeutic drugs (>230 projects) within the portfolio of 106 investigators, from Ceased to Marketed. In total the report assesses five different sub-indications of lympho ...

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In the BMI Business Environment Ranking for Q309, Zimbabwe remains firmly at the bottom of the matrix, which ranks 17 key markets surveyed in the Middle East and Africa (MEA) region, as well as globally. Zimbabwefs position is expected to show little i ...

Thailand Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMIfs Pharmaceutical Environment Ranking table for Q309, Thailand remains placed 10th, out of the 15 key markets surveyed in the Asia Pacific region. Thailandfs growing and ageing population and the expansion of universal healthcare coverage repres ...

Slovakia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Following an update to our macroeconomic variables as a result of both the eurozone accession and global economic downturn, BMI now expects Slovakiafs pharmaceutical expenditure to grow to EUR2.06bn (US$2.62bn) by 2013. While this is below our previous ...

Singapore Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMIfs Business Environment Rankings (BER) matrix for Q309, Singapore slipped from fourth to sixth position out of the 15 key countries in the Asia Pacific region, in line with worsening economic conditions and their impact on the pharmaceutical mark ...

Philippines Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
The Philippines remains ranked as the 11th most attractive pharmaceutical market among 15 major countries in the Asia Pacific region, according to BMIfs Business Environment Rankings for Q309. Nevertheless, BMI expects the country to improve this posit ...

Lebanon Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Lebanon remains a strong pharmaceutical market in the Middle East and Africa (MEA) region. In BMIfs updated Business Environment Ratings for Q309, Lebanon holds a respectable 13th position. The countryfs pharmaceutical market was worth US$500mn in 200 ...

Latvia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
BMI calculates the Latvian pharmaceutical market to have been worth LVL256mn (US$512mn) in 2008, and by 2013, drug expenditure is expected to reach a value of LVL352mn. In US dollar terms, however, as a result of the weakening lat, drug market spending ...

Kuwait Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Kuwaitfs pharmaceutical market is small in regional terms. Combined sales of over-the-counter (OTC) and prescription drugs reached a total of US$377mn in 2008, and we expect this to reach US$462mn by 2013 ? representing a compound annual growth rate (C ...

Israel Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
In BMIfs updated Business Environment Rankings (BER) for Q309, Israel continued slipping down the table, now ranking seventh out of the 17 Middle East and African (MEA) markets surveyed. While the country scores strongly across the country structure an ...

Greece Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Greecefs uncontrolled growth in drug expenditure, which increased by 59% between 2004 and 2008, has led the country to rank among the highest per capita spenders in Europe. While a proportion of this figure is likely attributable to the countryfs para ...

Germany Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Germanyfs drug market expenditure reached a value of EUR40.6bn (US$59.7bn) in 2008. The value of the countryfs pharmaceutical market is forecast to reach EUR48.6bn (US$61.6bn) by 2013, representing a compound annual growth rate (CAGR) of 3.69% in loca ...

Croatia Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Of the 20 markets measured in BMIfs Q309 Pharmaceuticals & Healthcare Business Environment Rankings for Central and Eastern Europe (CEE), Croatia is placed 10th, reflecting the countryfs middleranking attractiveness for multinational companies. While ...

Canada Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
For BMIfs Pharmaceutical and Healthcare Q309 Report for Canada, we believe the total drug market value will increase from US$22.4bn in 2008 to US$37.2bn by 2013, representing a compound annual growth rate (CAGR) of 10.7% in US dollar terms. We believe ...

Bangladesh Pharmaceuticals and Healthcare Report Q3 2009
Table of Contents Published: 2009/06 Published by: Business Monitor International
Out of the 15 key markets surveyed in BMIfs Pharmaceuticals & Healthcare Business Environment Rankings, Bangladesh is placed in 13th position, and can be found above Pakistan and Vietnam, the latter being judged the least attractive proposition for inv ...

Fibromyalgia Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for fibromyalgia. Datamonitor forecasts the fibromyalgia market to more than ...

Asthma and COPD Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
Although the respiratory market has expanded considerably from 2004 to 2008, growth in the seven major markets is slowing down from 2009 to 2011, after which sales will decline due to patent expiries of leading brands. Growth is driven by the expansion of ...

HIV Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiati ...

Commercial Insight: Cytotoxic Therapies - Market growth will slow due to increasing genericization
Table of Contents Published: 2009/06 Published by: Datamonitor
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued ...

Forecast Insight: Inflammatory Bowel Disease - New product launches sustain long-term market growth
Table of Contents Published: 2009/06 Published by: Datamonitor
The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. While Datamonitor' s updated forecast will parallel its previous forecast up to 2012, several new product launches, regi ...

Filling the Holes in the Drug Supply Chain (Strategic Focus)
Table of Contents Published: 2009/06 Published by: Datamonitor
The pharma industry is moving beyond the borders of US and Western Europe. As drug development costs reach astronomical levels, the burden to become lean falls on the manufacturers. To reduce costs, companies are moving their manufacturing facilities to o ...

Drug Delivery Technologies: Targeted Delivery Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
Despite considerable advances in drug delivery technologies, there continues to be a high unmet clinical need for safer and better-tolerated drugs. Sub-optimal compliance and failure to persist with drug treatments are important determinants of therapeuti ...

Drug Delivery Technologies: Nucleic Acid Delivery Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The nucleic acid delivery market is maturing with over 1,450 clinical trials underway worldwide. The majority of these are in early clinical development (approximately 60%) with just over 3% in Phase III trials. Our analysis indicates that up to 35 novel ...

Drug Delivery Technologies: Nano-enabled Delivery Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The true value of nanotechnology lies in its potential to improve the solubility and enhance the efficiency of product delivery. ...

Drug Delivery Technologies: Controlled-release Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The controlled-release market was worth nearly US$21 billion globally in 2008. The sector is dominated by the launch of oral controlled-release formulations in key therapeutic areas such as the central nervous system, cardiovascular, metabolic and respira ...

Cytotoxic Therapies Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued ...

Healthcare Technology Spending Through 2014 (Interactive Model)
Table of Contents Published: 2009/06 Published by: Datamonitor
As healthcare organizations increasingly turn to IT to decrease costs, improve the quality of care and increase access to care, it is important for technology vendors to understand where growth opportunities exist in the global healthcare market. ...

Innovations in In-Vitro Diagnostics: New technologies, growth opportunities, and the future market outlook
Table of Contents Published: 2009/06 Published by: Business Insights
Clinical diagnostics is an attractive and growing industry, with the majority of major diagnostic companies experiencing sales growth of over 10% in2008, despite significant pricing pressures. ...

Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
Table of Contents Published: 2009/06 Published by: Business Insights
The development of genomics-based molecular diagnostics that are linked to therapeutic products is critical to targeted drug developments of the future. ...

Emerging Clinical Trial Locations -Latin America: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that ...

Emerging Clinical Trial Locations - India: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

Emerging Clinical Trial Locations - China: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

Emerging Clinical Trial Locations - Eastern Europe: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment
Table of Contents Published: 2009/06 Published by: Business Insights
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. ...

North American and Western Europe Oral Solid Drug Dosage Excipients Markets
Table of Contents Published: 2009/06 Published by: Frost & Sullivan
This research service discusses trends and market metrics of the excipients market. ...

Pharmacogenomics: Delivering on the Promise
Table of Contents Published: 2009/06 Published by: Insight Pharma Reports
Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ...

Biotech Exit Strategies: Delivering value to investors in a challenging funding market
Table of Contents Published: 2009/06 Published by: Business Insights
Establishing the most effective route to exit for a biotech venture is critical in ensuring value is maximized for key stakeholders and the associated technology. However, more critical than selection of exit strategy is the planning and effective executi ...

The Pain Management Market Outlook To 2014: Competitive landscape, pipeline analysis and growth opportunities
Table of Contents Published: 2009/06 Published by: Business Insights
The global pain management market continued to demonstrate strong growth in 2007, despite patent expiries of leading products and strong generic competition. The NSAIDs segment of the market has overcome the impact of an FDA-imposed black box warning in 2 ...

The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast
Table of Contents Published: 2009/06 Published by: Business Insights
The Indian Pharmaceutical Market Outlook to 2014' provides comprehensive coverage of the Indian pharmaceutical market, incorporating the market structure, pricing and regulation and detailed analyses of the leading companies and likely healthcare reforms. ...

The Pricing and Reimbursement Environment for Immune Disease Therapies
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
Drug therapies for immune disorders span an enormous price range from a few cents per day to tens of thousands of dollars per year. Not surprisingly, payers impose restrictions on the use of the most expensive agents, especially biologics. These restrict ...

Pharmaceutical Pricing and Reimbursement in China
Table of Contents Published: 2009/06 Published by: Decision Resources, Inc.
With a growth rate of more than 20% per year, the Chinese pharmaceutical market is set to become the third largest in the world in 2011. A radical healthcare reform package recently unveiled by the government will more than double public healthcare expend ...

The World Medical Markets Fact Book 2009
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
In today' s challenging market environment the need to understand world medical marketplaces, and be able to answer quickly those questions that arise daily, is essential. Therefore an authoritative, current and comprehensive market intelligence source is ...

Drug Delivery Technologies: Players, products & prospects to 2018
Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence
The time when advanced drug delivery was merely a means for profitable product life extension has gone. Drug delivery is now a major component of the pharmaceutical industry' s future and critical to bringing novel therapies to market. Indeed, without ...

Global In Vitro Diagnostic Market Analysis
Table of Contents Published: 2009/06 Published by: RNCOS E-Services Pvt. Ltd.
The In vitro diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry. Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient ...


<< Previous Page:   7   8   9   10   11   12   13   14   15   16   17   18   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.